Skip to main content
Without effective antibiotics, accelerated action on NCDs is at risk
Global Cause
health, wealth and wellbeing of our world
Antimicrobial Resistance
Global Health Resilience
Women and Girls
Wildlife
More
Climate Action
About us
Infectious Diseases
World Food Day
World Oceans Day
Malaria
Circular Economy
Refugees & Migration
Clinical Trials
Vaccines and Immunisation
World Food Day & Sustainable Packaging
Farming
Water
Malaria & NTDs
Neglected Tropical Diseases
HIV AIDS
Maternal health
About us
Body Empowerment
Climate Change
Ending TB
Labour Exploitation
Make a difference
Plant-Based Alternatives
Plastic
Pride
Client survey
Climate Action
About us
Infectious Diseases
World Food Day
World Oceans Day
Malaria
Circular Economy
Refugees & Migration
Clinical Trials
Vaccines and Immunisation
World Food Day & Sustainable Packaging
Farming
Water
Malaria & NTDs
Neglected Tropical Diseases
HIV AIDS
Maternal health
About us
Body Empowerment
Climate Change
Ending TB
Labour Exploitation
Make a difference
Plant-Based Alternatives
Plastic
Pride
Client survey
Sponsored
African coordination can turn the tide on AMR
Sponsored
The five steps for a stronger African One Health response to AMR
Sponsored
Revolutionising UTIs diagnosis and treatment in 45 minutes
Sponsored
Why we still don’t have enough vaccines for bacterial threats
Sponsored
Patient-derived organoids are de-risking clinical drug development
Sponsored
Patents power innovation against antimicrobial resistance
Sponsored
Afabicin: A new generation of antibiotics to fight AMR
An independent biopharmaceutical company is committed to developing tomorrow’s standard of care, with first-in-class novel antibiotic afabicin (Debio 1450) showing remarkable promise in bone and joint infection. With surging AMR-infection coupled with a lack of alternatives to combat resistant pathogens,AMR is rapidly becoming a global public health emergency, a mission central to one Swiss biopharmaceutical … Continued
Sponsored
Phage therapy and the future of global antimicrobial resistance
Sponsored
A race against time: antimalarial drug resistance
Sponsored
Putting prevention at the heart of AMR strategies
AMR Q4 2025
Invisible frontlines: tackling antimicrobial resistance amid conflict and fragility
AMR Q4 2025
AMR is a preventable global crisis